Analysing Medication Errors in Clinical Negligence Cases

Why Medication Errors Matter in Clinical Negligence

Medication errors contribute to an estimated 712 deaths per year in NHS England and cost approximately £98 million annually, making them one of the most common and most preventable causes of patient harm. Unlike diagnostic errors involving contested clinical judgement, many medication errors involve verifiable departures from BNF prescribing standards — making breach of duty arguments more straightforward when the error is properly identified in the records.

Medication errors are among the most common and most preventable causes of patient harm in the NHS. According to research commissioned by the Department of Health and Social Care, medication errors contribute to an estimated 712 deaths per year in England and cost the NHS approximately £98 million annually. For clinical negligence solicitors, these errors represent a significant and recurring category of claims — and one where the evidence trail, when properly analysed, is often unusually clear.

Unlike diagnostic errors, which frequently involve contested clinical judgement, many medication errors involve verifiable departures from established prescribing standards. The British National Formulary (BNF) sets out recommended doses, contraindications, and monitoring requirements in unambiguous terms. When a prescriber departs from these standards without documented clinical justification, the breach of duty argument is often straightforward. The challenge lies in finding these errors within complex, voluminous medical records — and in establishing the causal link between the error and the patient's harm.

Types of Medication Errors in Negligence Cases

Seven categories of medication error appear in clinical negligence claims: wrong drug (including look-alike/sound-alike errors), wrong dose (the most frequently reported category, especially tenfold errors in paediatric weight-based prescribing), wrong route (rare but potentially fatal), omitted medications at care transitions, drug interactions between medications prescribed by different clinicians, allergy and sensitivity failures despite documented allergies, and monitoring failures for high-risk drugs like methotrexate, lithium, and warfarin.

Medication errors span the entire prescribing, dispensing, and administration chain. Understanding the categories is essential for systematic record review.

Wrong drug

Prescribing or administering the incorrect medication entirely. This includes look-alike/sound-alike errors (such as confusing chlorpromazine with chlorpropamide), prescribing a drug that is inappropriate for the patient's condition, or selecting a medication from the wrong class. Wrong-drug errors are often high severity because the patient receives a substance that was never intended for them, with unpredictable consequences.

Wrong dose

Dosage errors are the most frequently reported category of prescribing error in the UK, accounting for 25–30% of all prescribing errors. They range from tenfold calculation mistakes — particularly common in paediatric prescribing where doses are weight-based — to more subtle failures such as not adjusting the dose for renal impairment (eGFR below 30 mL/min) or hepatic impairment. The BNF provides clear dosage ranges for each indication, and departures from these ranges without documented justification are strong indicators of substandard care.

Wrong route

Administering a medication via the incorrect route — for example, giving an intrathecal injection of a drug intended for intravenous use. Wrong-route errors account for 2–5% of prescribing errors but can be catastrophic. The accidental intrathecal administration of vincristine, for instance, has been the subject of multiple NPSA (National Patient Safety Agency) patient safety alerts and has caused deaths in the UK.

Omitted medications

Failing to prescribe or administer a medication that the patient requires. This includes omissions at transitions of care — such as medications being dropped from a drug chart during hospital admission or discharge — and failures to prescribe evidence-based treatments altogether. Omissions at discharge are particularly common (affecting an estimated 30–40% of hospital discharges) and can have serious consequences when critical medications such as anticoagulants, insulin, or anti-epileptics are interrupted.

Drug interactions

Prescribing two or more medications that interact adversely without appropriate monitoring or dose adjustment. Clinically significant interactions are documented in the BNF and flagged by electronic prescribing systems, so a failure to identify a known interaction raises immediate questions about prescribing competence. Common examples in negligence cases include combining QT-prolonging drugs, co-prescribing warfarin with drugs that potentiate its effect without increased INR monitoring, and prescribing NSAIDs alongside anticoagulants.

Allergy and sensitivity failures

Prescribing or administering a medication to which the patient has a documented allergy or known sensitivity. Allergy status should be recorded prominently in the medical notes, on drug charts, and in electronic prescribing systems. When a patient with a documented penicillin allergy is prescribed amoxicillin and suffers an anaphylactic reaction, the negligence case is often unanswerable — the information was available, and the prescriber failed to check it.

Monitoring failures

Many medications require ongoing monitoring to ensure therapeutic efficacy and detect adverse effects. Methotrexate requires full blood count and liver function monitoring every 1–2 weeks until stable, then every 2–3 months. Lithium requires serum level checks every 3–6 months. Aminoglycosides require renal function monitoring and therapeutic drug monitoring. A failure to arrange or act on required monitoring — where the failure leads to a preventable adverse effect — is a well-established basis for negligence claims.

Where to Find Medication Information in Medical Records

Medication evidence is distributed across five record sources that must be cross-referenced for a complete picture: inpatient drug charts and ePMA systems (what was prescribed and whether each dose was administered), GP prescribing records (longitudinal prescribing history and repeat prescriptions), discharge summaries (critical transition point where 30–40% of omission errors occur), pharmacy records (independent evidence of prescribing quality and interventions), and clinical correspondence (specialist medication recommendations and implementation).

Medication evidence is rarely confined to a single document. A thorough analysis requires examining multiple record sources, cross-referencing them for consistency and completeness.

Inpatient drug charts (medication administration records)

The primary source for hospital prescribing. Drug charts record what was prescribed, the dose, route, frequency, and — critically — whether each dose was actually administered. Gaps in administration records (missing signatures) may indicate omitted doses. Some NHS trusts now use electronic prescribing and medicines administration (ePMA) systems, which generate more detailed audit trails but can produce voluminous records.

GP prescribing records

The GP record provides the longitudinal prescribing history. It shows repeat prescriptions, medication changes over time, and — importantly — the clinical rationale (or lack thereof) for prescribing decisions. GP records are essential for identifying long-term prescribing failures, such as continuing a medication without appropriate monitoring or failing to review a high-risk prescription at the recommended intervals.

Discharge summaries and transfer letters

Discharge summaries are a critical transition point where medication errors frequently occur. Comparing the discharge medication list against the admission drug chart and the patient's pre-admission medications can reveal unintended omissions, doses that changed without explanation, or new medications started without adequate handover to the GP. NICE guideline NG5 (Medicines optimisation) emphasises the importance of medicines reconciliation at every transfer of care.

Pharmacy records and clinical pharmacist notes

Hospital pharmacy teams often review prescriptions and may document interventions — corrections to prescribing errors, dose adjustments, or interaction warnings. These records provide independent evidence of prescribing quality and can confirm whether errors were identified and corrected, or whether they persisted unchecked.

Clinical correspondence and clinic letters

Outpatient clinic letters and specialist correspondence frequently contain medication recommendations. When a specialist recommends a specific treatment and the GP does not implement it — or vice versa — the correspondence trail can establish precisely where the failure occurred and who was responsible.

Relevant Guidelines and Standards

Five sources establish the expected prescribing standard for medication error claims: the BNF (primary reference for all UK prescribing, covering doses, contraindications, interactions, and monitoring), NICE guidelines (including NG5 on medicines optimisation and CG76 on medicines adherence), NPSA/NHS England patient safety alerts addressing known medication risks, local trust formularies and protocols with additional monitoring requirements, and the GMC's Good Practice in Prescribing guidance setting professional standards for all prescribers.

Establishing breach of duty in medication error cases requires reference to the prescribing standards that were in force at the time of the care. The key sources are:

• British National Formulary (BNF): The primary reference for prescribing in the UK. The BNF sets out indications, contraindications, dosage ranges, interactions, and monitoring requirements. Departures from BNF recommendations carry significant weight because the BNF represents the standard reference that all UK prescribers are expected to consult.
• NICE guidelines: Where NICE has issued guidance on specific conditions or medication classes — such as NG5 (Medicines optimisation), CG76 (Medicines adherence), or condition-specific guidelines that include prescribing recommendations — these set the expected standard of care.
• NPSA and NHS England patient safety alerts: Safety alerts issued in response to known medication risks carry particular evidential weight. When an error occurs that was specifically addressed by a prior safety alert, the argument that the prescriber should have been aware of the risk is compelling.
• Local trust formularies and protocols: Many NHS trusts maintain local prescribing guidelines and formularies that supplement the BNF. These can set additional standards — for example, requiring specific monitoring frequencies or restricting certain prescribing decisions to specialist teams.
• GMC Good Practice in Prescribing and Managing Medicines and Devices: The GMC's guidance sets out the professional standards expected of all prescribers, including requirements around competence, record-keeping, monitoring, and acting within the limits of one's knowledge.

Establishing Breach of Duty for Medication Errors

Medication errors often present a more straightforward breach argument than other negligence categories because the BNF codifies objective prescribing standards. When a patient is prescribed 2,000mg instead of 200mg due to a decimal point error, the departure from the standard is measurable and not a matter of clinical judgement. The Bolam defence — that a body of responsible practitioners would have acted the same way — cannot apply to factual prescribing mistakes. However, off-label prescribing and specialist dose adjustments may be defensible when clinically justified and documented.

The legal framework for medication error claims follows the standard clinical negligence structure under the Bolam test as modified by Bolitho: the claimant must show that no responsible body of medical practitioners would have prescribed (or failed to prescribe) in the manner that occurred, and that this opinion withstands logical analysis.

Medication errors often present a more straightforward breach argument than other negligence categories because the expected standard is frequently codified in the BNF. Consider the difference between:

• A diagnostic delay claim, where reasonable clinicians may disagree on whether an earlier investigation was warranted based on the presenting symptoms.
• A prescribing error claim, where the BNF states a maximum dose of 200mg and the patient was prescribed 2,000mg due to a decimal point error.

In the second scenario, the departure from the standard is objective and measurable. The defence cannot rely on the Bolam principle — that a body of responsible practitioners would have acted the same way — because the BNF recommendation is clear and the error is a factual mistake rather than a clinical judgement call.

That said, breach is not always straightforward. Off-label prescribing, for example, is legitimate when clinically justified and documented. The key question is whether the prescriber had a rational basis for the decision and whether they communicated the risks to the patient. Similarly, departing from BNF dose ranges may be appropriate in specialist contexts — but the onus is on the clinician to document why.

AI-Powered Medication Compliance Analysis

MedCase AI runs 7 parallel analyses across the medical records simultaneously, with four directly targeting medication errors: medication and prescribing analysis (comparing every prescription against BNF dosage ranges and contraindications), drug interaction screening (cross-referencing the full medication list across providers and time periods), monitoring compliance analysis (verifying required blood tests and serum levels at correct intervals), and transition of care analysis (comparing medication lists at admission, discharge, and transfer points to identify unintended omissions).

The challenge with medication error cases is not usually establishing that an error constitutes a breach — it is finding the error in the first place. A patient who has been under NHS care for several years may have medical records running to thousands of pages, with prescribing information scattered across GP records, hospital drug charts, discharge summaries, and clinic letters. Manual review of this volume is slow, expensive, and prone to overlooking errors that are embedded deep in the documentation.

MedCase AI addresses this by running seven parallel analyses across the medical records simultaneously. Each analysis examines the records from a different clinical perspective — and several of these are directly relevant to identifying medication errors:

• Medication and prescribing analysis: Systematically compares every prescribed medication against BNF dosage ranges, checks for documented contraindications, and identifies prescriptions that lack recorded clinical justification. This analysis catches dosage errors, wrong-drug prescriptions, and inappropriate prescribing that a sequential manual review might miss.
• Drug interaction screening: Cross-references the patient's full medication list — including medications prescribed by different clinicians at different times — to identify clinically significant interactions. Because the analysis considers the entire prescribing history simultaneously using 1,536-dimension vector embeddings, it can detect interactions between medications prescribed months apart by different services, a pattern that is particularly difficult to identify manually.
• Monitoring compliance analysis: Checks whether required monitoring was performed at the appropriate intervals. For each medication that requires ongoing monitoring (such as methotrexate, lithium, warfarin, or disease-modifying anti-rheumatic drugs), the analysis verifies that the corresponding blood tests, serum levels, or clinical assessments were documented in the records at the BNF-recommended intervals.
• Transition of care analysis: Examines medication lists at each care transition — admission, discharge, transfer between services — to identify medications that were unintentionally omitted, doses that changed without explanation, or new medications started without adequate handover to the ongoing prescriber.

The result is a comprehensive medication compliance assessment that would take an expert many hours to replicate manually. Each identified error is linked to the specific record entry where it appears, cross-referenced against the relevant BNF or NICE recommendation, and assigned a severity score from 1–10 reflecting its clinical and legal significance. The entire analysis processes files up to 2 GB in size and completes in minutes rather than the hours or days required for manual review.

Documenting Medication Findings with Evidence

Each medication error finding must include five elements for litigation use: a precise description of the error, source references with dates and document locations, the specific BNF or NICE standard that was breached, the clinical consequence for the patient, and a severity score from 1–10. The strongest findings draw evidence from multiple record sources — drug charts, discharge summaries, GP records, and correspondence — demonstrating systemic failure rather than a single slip, and implicating multiple clinicians across care settings.

Identifying a medication error is only the first step. For the finding to be useful in litigation, it must be documented in a way that connects the error to the evidence, the relevant standard, and the patient outcome.

Structure each finding clearly

An effective medication error finding should include:

• The error: A precise description of what occurred — for example, "Patient prescribed methotrexate 15mg weekly but no full blood count monitoring documented for a period of 14 weeks."
• The source: The specific record entry or entries where the error is evidenced, with dates and document references.
• The standard: The guideline or prescribing reference that was not followed — for example, "BNF recommends FBC monitoring every 1–2 weeks until therapy stabilised, then every 2–3 months."
• The consequence: What happened to the patient as a result — for example, "Patient developed pancytopenia requiring hospital admission, which may have been identified earlier with appropriate monitoring."
• Severity assessment: A score from 1–10 reflecting the clinical and legal significance of the finding, with scores of 8–10 indicating critical errors with direct patient harm.

Cross-reference multiple record sources

The strongest findings draw evidence from multiple parts of the record. A prescribing error identified on a drug chart is more compelling when the discharge summary repeats the incorrect dose, the GP record shows the prescription was continued in the community, and the clinical correspondence contains no discussion of the rationale. This pattern demonstrates a systemic failure rather than a single slip, and it implicates multiple clinicians across multiple care settings.

Preserve the timeline

Medication errors must be placed in their temporal context. When was the drug first prescribed? When should monitoring have occurred? When did the adverse effect manifest? How long was the window during which the error could have been identified and corrected? This timeline is essential for establishing causation — demonstrating that earlier detection of the error would, on the balance of probabilities, have prevented or reduced the patient's harm.

MedCase AI generates these structured, evidence-linked findings automatically, presenting each medication error with its source references, the applicable BNF or NICE guideline, and a severity score from 1–10. This gives solicitors a ready-made foundation for instructing experts and building legal arguments, while ensuring that the underlying evidence is traceable and verifiable.

Medication errors represent one of the most evidence-rich categories of clinical negligence. The prescribing standards are well documented, the record trail is often detailed, and the causal link between error and harm is frequently demonstrable. The difficulty lies in the volume and fragmentation of the evidence — prescribing information spread across drug charts, GP records, discharge summaries, and specialist correspondence, often spanning years of care.

For solicitors assessing medication negligence cases, the ability to analyse this evidence systematically — cross-referencing every prescription against the BNF, checking every required monitoring interval, and screening the full medication history for interactions — is the difference between catching a critical error and missing it entirely. Request a demo to see how MedCase AI performs this analysis across thousands of pages of medical records, identifying the prescribing failures that matter most to your case.